{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:24:13Z","timestamp":1786998253576,"version":"build-2736575974"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["GW58292-11653"],"award-info":[{"award-number":["GW58292-11653"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy &amp; Behavior"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.yebeh.2014.06.010","type":"journal-article","created":{"date-parts":[[2014,7,10]],"date-time":"2014-07-10T07:31:24Z","timestamp":1404977484000},"page":"123-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Retigabine calms seizure-induced behavior following status epilepticus"],"prefix":"10.1016","volume":"37","author":[{"given":"A.M.","family":"Slomko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Naseer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.S.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Wongvravit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.K.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2014.06.010_bb0005","article-title":"Are children affected by epileptic neuropsychiatric comorbidities?","author":"Terra","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0010","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrd3561","article-title":"Ezogabine (retigabine)","volume":"10","author":"Stafstrom","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0015","first-page":"409","article-title":"Profile of ezogabine (retigabine) and its potential as an adjunctive treatment for patients with partial-onset seizures","volume":"7","author":"Weisenberg","year":"2011","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0020","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev.ne.15.030192.002033","article-title":"The role of the amygdala in fear and anxiety","volume":"15","author":"Davis","year":"1992","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0014-2999(96)00073-8","article-title":"D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures","volume":"303","author":"Tober","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.eplepsyres.2007.02.001","article-title":"Phenytoin- and carbamazepine-resistant spontaneous bursting in rat entorhinal cortex is blocked by retigabine in vitro","volume":"74","author":"Smith","year":"2007","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0035","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0006-8993(97)01110-4","article-title":"Long-term kindling and interictal emotionality in rats: effect of stimulation site","volume":"779","author":"Kalynchuk","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0045","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nprot.2007.44","article-title":"The use of the elevated plus maze as an assay of anxiety-related behavior in rodents","volume":"2","author":"Walf","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0050","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1460-9568.2009.06624.x","article-title":"Context conditioning and extinction in humans: differential contribution of the hippocampus, amygdala and prefrontal cortex","volume":"29","author":"Lang","year":"2009","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0055","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/hbm.20867","article-title":"Individual sensitivity to pain expectancy is related to differential activation of the hippocampus and amygdala","volume":"31","author":"Ziv","year":"2010","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0060","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1146\/annurev.neuro.24.1.897","article-title":"Neurobiology of Pavlovian fear conditioning","volume":"24","author":"Maren","year":"2001","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0065","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1037\/0735-7044.118.1.97","article-title":"Hippocampus and Pavlovian fear conditioning in rats: muscimol infusions into the ventral, but not dorsal, hippocampus impair the acquisition of conditional freezing to an auditory conditional stimulus","volume":"118","author":"Maren","year":"2004","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0070","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1037\/0735-7044.106.2.274","article-title":"Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning","volume":"106","author":"Phillips","year":"1992","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0075","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/ejn.12057","article-title":"Hemodynamic responses in amygdala and hippocampus distinguish between aversive and neutral cues during Pavlovian fear conditioning in behaving rats","volume":"37","author":"McHugh","year":"2013","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0080","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1600-0404.2008.01108.x","article-title":"Seizures in the intrahippocampal kainic acid epilepsy model: characterization using long-term video-EEG monitoring in the rat","volume":"119","author":"Raedt","year":"2009","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0085","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.eplepsyres.2012.09.015","article-title":"The intrahippocampal kainate model of temporal lobe epilepsy revisited: epileptogenesis, behavioral and cognitive alterations, pharmacological response, and hippoccampal damage in epileptic rats","volume":"103","author":"Rattka","year":"2013","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0090","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0304-3940(79)96117-2","article-title":"Intrahippocampal injections of ibotenic acid provide histological evidence for a neurotoxic mechanism different from kainic acid","volume":"15","author":"K\u00f6hler","year":"1979","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0095","doi-asserted-by":"crossref","first-page":"9412","DOI":"10.1523\/JNEUROSCI.19-21-09412.1999","article-title":"Unilateral GluR2(B) hippocampal knockdown: a novel partial seizure model in the developing rat","volume":"19","author":"Friedman","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2005.09.010","article-title":"Perinatal seizures preferentially protect CA1 neurons from seizure-induced damage in prepubescent rats","volume":"15","author":"Liu","year":"2006","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0105","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0028-3908(89)90170-6","article-title":"Comparison of changes in the EEG of freely moving rats induced by enciprazine, buspirone and diazepam","volume":"28","author":"Nickel","year":"1989","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0110","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0013-4694(72)90176-9","article-title":"Modification of seizure activity by electrical stimulation. I. After-discharge threshold","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0115","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1523\/JNEUROSCI.16-04-01337.1996","article-title":"Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death","volume":"16","author":"Morrison","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0120","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/00912700222011210","article-title":"Multiple-dose, linear, dose-proportional pharmacokinetics of retigabine in healthy volunteers","volume":"42","author":"Ferron","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0125","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1159\/000100078","article-title":"Maturational effects of single and multiple early-life seizures on AMPA receptors in prepubescent hippocampus","volume":"29","author":"Friedman","year":"2007","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0130","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0165-0270(80)90021-7","article-title":"AChE-stained horizontal sections of the rat brain in stereotaxic coordinates","volume":"3","author":"Paxinos","year":"1980","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0135","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.neuropharm.2011.10.016","article-title":"Retigabine, a KV7 (KCNQ) potassium channel opener, attenuates l-DOPA-induced dyskinesias in 6-OHDA-lesioned rats","volume":"62","author":"Sander","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0140","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1006\/ebeh.2000.0122","article-title":"Nonconvulsive kainic acid-induced seizures elicit age-dependent impairment of memory for the elevated plus-maze","volume":"1","author":"Mikuleck\u00e1","year":"2000","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0145","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.brainres.2005.09.037","article-title":"Behavioral changes resulting from the administration of cycloheximide in the pilocarpine model of epilepsy","volume":"1066","author":"Dos Santos","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0150","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1124\/jpet.105.083923","article-title":"Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels","volume":"314","author":"Korsgaard","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0155","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1749-6632.2003.tb07096.x","article-title":"Neuroimaging studies of amygdala function in anxiety disorders","volume":"985","author":"Rauch","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0160","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0006-3223(02)01733-X","article-title":"Rodent doxapram model of panic: behavioral effects and c-Fos immunoreactivity in the amygdala","volume":"53","author":"Sullivan","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0165","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1523\/JNEUROSCI.20-07-02701.2000","article-title":"Neuronal correlates of fear in the lateral amygdala: multiple extracellular recordings in conscious cats","volume":"20","author":"Par\u00e9","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0170","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1749-6632.2003.tb07095.x","article-title":"Brain imaging studies in mood and anxiety disorders: special emphasis on the amygdala","volume":"985","author":"Anand","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0175","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1113\/jphysiol.1992.sp019366","article-title":"Muscarinic inhibition of M-current and a potassium leak conductance in neurones of the rat basolateral amygdala","volume":"457","author":"Womble","year":"1992","journal-title":"J Physiol"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0180","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1523\/JNEUROSCI.21-13-04609.2001","article-title":"Differential expression of genes encoding subthreshold-operating voltage-gated K+ channels in brain","volume":"21","author":"Saganich","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0185","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1124\/mol.108.052282","article-title":"Refinement of the binding site and mode of action of the anticonvulsant retigabine on KCNQ K+ channels","volume":"75","author":"Lange","year":"2009","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.yebeh.2014.06.010_bb0190","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1528-1167.2011.03365.x","article-title":"The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy","volume":"53","author":"Gunthorpe","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0195","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.279.5349.403","article-title":"A potassium channel mutation in neonatal human epilepsy","volume":"279","author":"Biervert","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0200","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng0198-25","article-title":"A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns","volume":"18","author":"Singh","year":"1998","journal-title":"Nat Genet"},{"issue":"Suppl. 5","key":"10.1016\/j.yebeh.2014.06.010_bb0205","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1528-1157.2001.0420s5049.x","article-title":"Potassium channels: how genetic studies of epileptic syndromes open paths to new therapeutic targets and drugs","volume":"42","author":"Cooper","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0210","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1111\/j.1528-1167.2008.01674.x","article-title":"Antiepileptogenic and antiictogenic effects of retigabine under conditions of rapid kindling: an ontogenic study","volume":"49","author":"Mazarati","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0215","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ana.23600","article-title":"Neonatal exposure to antiepileptic drugs disrupts striatal synaptic development","volume":"72","author":"Forcelli","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0220","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1124\/mol.61.4.921","article-title":"Effects of the anticonvulsant retigabine on cultured cortical neurons: changes in electroresponsive properties and synaptic transmission","volume":"61","author":"Otto","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0225","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0014-2999(03)01426-2","article-title":"Synergy between retigabine and GABA in modulating the convulsant site of the GABAA receptor complex","volume":"464","author":"van Rijn","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0230","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0091-3057(95)00153-N","article-title":"Regulation of anxiety by GABAA receptors in the rat amygdala","volume":"52","author":"Sanders","year":"1995","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0235","series-title":"Efficacy of retigabine on acute limbic seizures in adult rats","first-page":"534.07","author":"Friedman","year":"2013"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0240","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0306-4522(85)90299-4","article-title":"Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy","volume":"14","author":"Ben-Ari","year":"1985","journal-title":"Neuroscience"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0245","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0306-4522(98)00003-7","article-title":"Persistence of the interictal emotionality produced by long-term amygdala kindling in rats","volume":"85","author":"Kalynchuk","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0250","doi-asserted-by":"crossref","first-page":"e72336","DOI":"10.1371\/journal.pone.0072336","article-title":"A macaque model of mesial temporal lobe epilepsy induced by unilateral intrahippocampal injection of kainic acid","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0255","doi-asserted-by":"crossref","first-page":"11100","DOI":"10.1523\/JNEUROSCI.0472-13.2013","article-title":"Early activation of ventral hippocampus and subiculum during spontaneous seizures in a rat model of temporal lobe epilepsy","volume":"33","author":"Toyoda","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0260","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0014-2999(99)00786-4","article-title":"Retigabine strongly reduces repetitive firing in rat entorhinal cortex","volume":"386","author":"Hetka","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0265","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejphar.2007.05.029","article-title":"The neuronal KCNQ channel opener retigabine inhibits locomotor activity and reduces forebrain excitatory responses to the psychostimulants cocaine, methylphenidate and phencyclidine","volume":"570","author":"Hansen","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0270","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1744-8069-6-49","article-title":"Activation of voltage-gated KCNQ\/Kv7 channels by anticonvulsant retigabine attenuates mechanical allodynia of inflammatory temporomandibular joint in rats","volume":"6","author":"Xu","year":"2010","journal-title":"Mol Pain"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0275","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.neuropharm.2008.04.006","article-title":"Retigabine reduces the excitability of unmyelinated peripheral human axons","volume":"54","author":"Lang","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0280","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0014-2999(02)02924-2","article-title":"The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain","volume":"460","author":"Blackburn-Munro","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0285","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.neuropharm.2007.07.002","article-title":"Pharmacological comparison of anticonvulsant drugs in animal models of persistent pain and anxiety","volume":"53","author":"Munro","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0290","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1111\/j.1528-1167.2007.01222.x","article-title":"Psychiatric comorbidity in epilepsy: a population-based analysis","volume":"48","author":"Tellez-Zenteno","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.06.010_bb0295","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.yebeh.2012.01.008","article-title":"Depression and epilepsy, pain and psychogenic non-epileptic seizures: clinical and therapeutic perspectives","volume":"24","author":"Kanner","year":"2012","journal-title":"Epilepsy Behav"}],"container-title":["Epilepsy &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505014002169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505014002169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T10:17:42Z","timestamp":1716977862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505014002169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":59,"alternative-id":["S1525505014002169"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2014.06.010","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retigabine calms seizure-induced behavior following status epilepticus","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2014.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}